Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avinya Fund (also known as Avinya Capital) is a healthcare-focused investment and incubation firm based in Monmouth Junction, New Jersey, and India. Founded by pharmaceutical entrepreneur Vimal Kavuru, the firm specializes in the creation and growth of biopharmaceutical companies focused on specialty pharmaceuticals and orphan drugs. Avinya operates by identifying unmet medical needs in areas such as rare diseases, oncology, and central nervous system disorders, and providing the necessary capital and operational expertise to advance candidates through the clinic. One of the firm’s most significant achievements was the incubation of Grace Therapeutics, whose rare disease pipeline was later integrated into Acasti Pharma following a strategic merger. Avinya continues to manage a diverse portfolio of healthcare investments, leveraging a team of experts with deep experience in drug development, regulatory affairs, and commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avinya Fund.